TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN

Agonists for TLR9 and Stimulator of IFN Gene (STING) act as vaccine adjuvants that induce type-1 immune responses. However, currently available CpG oligodeoxynucleotide (ODN) (K-type) induces IFNs only weakly and STING ligands rather induce type-2 immune responses, limiting their potential therapeut...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Eur J Immunol
Prif Awduron: Temizoz, Burcu, Kuroda, Etsushi, Ohata, Keiichi, Jounai, Nao, Ozasa, Koji, Kobiyama, Kouji, Aoshi, Taiki, Ishii, Ken J
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Ltd 2015
Pynciau:
Innate Immunity
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4671267/
https://ncbi.nlm.nih.gov/pubmed/25529558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.201445132
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg